首页> 外文期刊>Toxics >Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science
【24h】

Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science

机译:毒理学和医学中的放射性碳示踪剂:技术和科学的最新进展

获取原文
           

摘要

This review summarizes recent developments in radiocarbon tracer technology and applications. Technologies covered include accelerator mass spectrometry (AMS), including conversion of samples to graphite, and rapid combustion to carbon dioxide to enable direct liquid sample analysis, coupling to HPLC for real-time AMS analysis, and combined molecular mass spectrometry and AMS for analyte identification and quantitation. Laser-based alternatives, such as cavity ring down spectrometry, are emerging to enable lower cost, higher throughput measurements of biological samples. Applications covered include radiocarbon dating, use of environmental atomic bomb pulse radiocarbon content for cell and protein age determination and turnover studies, and carbon source identification. Low dose toxicology applications reviewed include studies of naphthalene-DNA adduct formation, benzo[a]pyrene pharmacokinetics in humans, and triclocarban exposure and risk assessment. Cancer-related studies covered include the use of radiocarbon-labeled cells for better defining mechanisms of metastasis and the use of drug-DNA adducts as predictive biomarkers of response to chemotherapy.
机译:这篇综述总结了放射性碳示踪技术和应用的最新发展。涵盖的技术包括加速器质谱(AMS),包括将样品转化为石墨,以及快速燃烧为二氧化碳以实现直接的液体样品分析,与HPLC耦合以进行实时AMS分析,以及结合分子质谱和AMS进行分析物鉴定和定量。诸如腔衰荡光谱法等基于激光的替代方法正在出现,以实现生物样品的低成本,高通量测量。涉及的应用包括放射性碳测年,使用环境原子弹脉冲放射性碳含量进行细胞和蛋白质年龄确定和周转研究以及碳源识别。审查的低剂量毒理学应用包括萘-DNA加合物形成,人体中苯并[a] py药代动力学,三氯卡班暴露和风险评估的研究。涵盖的与癌症相关的研究包括使用放射性碳标记的细胞更好地确定转移机制,以及使用药物-DNA加合物作为对化学疗法反应的预测性生物标志物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号